Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Telcon RF Pharmaceutical

Telcon RF Pharmaceutical
1999 FOUNDED
PUBLIC STATUS
101-200 EMPLOYEES
200230 STOCK SYMBOL
1 INVESTMENTS
$3.93 SHARE PRICE (As of Wednesday Closing)
Description

Telcon RF Pharmaceutical Inc manufactures wireless communication equipment. It is engaged in developing connectors for input and output port, board to board, cable assembly, and board to mount used in wireless communication equipment. The company also supply's RF coaxial connectors.

Ownership Status
Publicly Held
Financing Status
Private Equity-Backed
Primary Industry
Electrical Equipment
Other Industries
Connectivity Products
Fiberoptic Equipment
Stock Exchange
KRX
Primary Office
  • 183-6 Yeongcheon-ro
  • Dongtan-myeon
  • Hwaseong-si, Gyeonggi-do
  • South Korea

+82 000-000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Telcon RF Pharmaceutical’s full profile, request a free trial.

Telcon RF Pharmaceutical Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$2.89 - $9.33 $326M $3.95 3.19M 83M

Telcon RF Pharmaceutical Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 350,446 621,325 1,042,891 216,421
Revenue 50,278 52,505 36,288 25,612
EBITDA 4,618 (5,749) (13,800) (4,464)
Net Income (985) (12,514) (14,498) (3,638)
Total Assets 153,373 162,563 196,183 98,012
Total Debt 18,405 17,132 61,913 17,345
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Telcon RF Pharmaceutical Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Telcon RF Pharmaceutical‘s full profile, request access.

Request full access to PitchBook

Telcon RF Pharmaceutical Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 10-Aug-2016 000000000 000.00 Drug Discovery
To view this company’s complete investment and acquisition history, request access »

Telcon RF Pharmaceutical Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Telcon RF Pharmaceutical‘s full profile, request access.

Request full access to PitchBook

Telcon RF Pharmaceutical Executive Team (1)

Name Title Board
Seat
Contact
Info
Jin-hun Lim Chief Executive Officer and President